Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2020 Feb 17;33:117–125. doi: 10.1016/j.euroneuro.2020.01.014

Table 1:

Demographical, neurocognitive and clinical characteristics in groups of controls and ADHD probands (including ADHD remitters and persisters).

Controls
(N = 35)
ADHD
(N = 32)
Remitters
(N=16)
Persisters
(N=16)
Mean (SD Mean (SD) P Mean (SD) Mean (SD) p
Age 24.24 (2.3) 24.60 (2.1) 0.51 24.81 (2.3) 24.39 (1.9) 0.57
Full-scale IQ 104.21 (15) 96.81 (14.3) 0.07 99.58 (14.2) 94.11 (11.5) 0.24
Socioeconomic status 51.59 (14.8) 43.73 (17.2) 0.06 43.28 (14.9) 40.56 (19.8) 0.57
CAARS (raw score)
 Inattentive 4.03 (3.5) 8.09 (5.1) <0.001 5.75 (4.9) 10.44 (4.3) 0.007
 Hyperacitive/impuls 4.58 (2.6) 8.66 (4.9) <0.001 5.88 (3.8) 11.44 (4.3) 0.001
 ADHD Total 8.82 (5.2) 16.59 (9.2) <0.001 11.94 (8.2) 21.25 (7.9) 0.003
N (%) N (%) P N (%) N (%) P
Male 30 (85.7) 27 (84.4) 0.88 14 (87.5) 13 (81.3) 0.63
Right-handed 31 (88.6) 28 (87.5) 0.89 14 (87.5) 14 (87./5) 1
Race 0.41 0.70
Caucasian 14 (40.0) 17 (53.1) 8 (50.0) 9 (56.3)
African American 13 (37.1) 7 (21.9) 4 (25.0) 3 (18.8)
More than one race 6 (17.1) 8 (25) 4 (25.0) 4 (25.0)
Asian 2 (5.7) 0 (0) 0 (0) 0 (0)
Ethnicity 0.21 0.72
Hispanic/Latino 12 (34.3) 15 (46.9) 7 (43.8) 8 (50.0)

CAARS: Conners’ Adult ADHD Rating Scale